Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in glioma
Abstract The immunosuppressive tumor microenvironment of glioblastoma limits the effectiveness of most immunotherapies. Transforming growth factor (TGF)-β signaling drives tumor progression and prevents effective T cell activity. Notably, both regulatory T cells (Tregs) and effector T cells within g...
Saved in:
Main Authors: | Daniela Lorizio, Manuela Silginer, Julia Friesen, Alan L. Epstein, Michael Weller, Patrick Roth |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-06-01
|
Series: | Cancer Immunology, Immunotherapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00262-025-04098-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Cellular Immune Theranostic Approaches for Glioblastoma: Current Trends and Future Directions
by: Ying Gong, et al.
Published: (2025-08-01) -
Immunotherapy in Glioblastoma: An Overview of Current Status
by: Sarfraz Z, et al.
Published: (2025-07-01) -
Immunotherapy of malignant gliomas: a modern view on the problem
by: А. А. Pichugin, et al.
Published: (2024-12-01) -
Emerging Chemotherapy Targets: Insights from Advances in Glioma Treatment
by: Rogina Rezk, et al.
Published: (2025-06-01) -
Experience in the use of dendritic vaccines in the treatment of patients with recurrent gliomas
by: M. Yu. Rykov, et al.
Published: (2022-12-01)